Interestingly, when patients were stratified based on tumor-associated increases or decrease in SELENOP expression relative to their own normal tissue, most other selenoproteins were consistently upregulated in tumors in both subgroups (Fig. 1D). The gene discussed is SELENOP; the disease is neoplasm.